Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Philip Brenner, Adam Nygren, David Hägg, Mikael Tiger, Marguerite O’Hara, Lena Brandt & Johan Reutfors. (2022) Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study. International Journal of Psychiatry in Clinical Practice 26:3, pages 251-258.
Read now
Read now
Articles from other publishers (4)
Leanne M. Williams, William T. Carpenter, Carrie Carretta, Evangelos Papanastasiou & Uma Vaidyanathan. (2023) Precision psychiatry and Research Domain Criteria: Implications for clinical trials and future practice. CNS Spectrums 29:1, pages 26-39.
Crossref
Crossref
Ludivine Boudieu, Myriam Mennetrier, Pierre-Michel Llorca & Ludovic Samalin. (2023) The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review. Pharmaceutics 15:12, pages 2773.
Crossref
Crossref
Kimberlyn Maravet Baig-Ward, Manish Kumar Jha & Madhukar H. Trivedi. (2023) The Individual and Societal Burden of Treatment-Resistant Depression. Psychiatric Clinics of North America 46:2, pages 211-226.
Crossref
Crossref
Valerie L. Forman-Hoffman, Joseph C. Kvedar & Kristian Ranta. (2021) Potential Benefits of Remote Continuous Care for Depression. International Journal of Digital Health 1:1.
Crossref
Crossref